CO [Global Cord Blood] 6-K: (Original Filing)

[Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020 1Q20 Added 20,815 New Subscribers Revenues Up 16.9% YoY to RMB273.4 Million ($39.8 Million) Gross Profit Up 19.4% YoY to RMB227.6 million ($33.2 million) Operating Income Up 17.8% YoY to RMB112.4 Million ($1]

By | 2019-08-28T03:48:44+00:00 August 27th, 2019|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

IDI [Fluent] 424B3: (Original Filing)

[Registration No. 333-233250 Prospectus FLUENT, INC. 1,565,443 Shares of Common Stock Our common stock is traded on the Nasdaq Global Market (“ NASDAQ ”) under the symbol “FLNT.” The last reported sale price of our common stock on August 12, 2019 was $3.01 per share. Investing in our securities invol]

By | 2019-08-28T03:49:10+00:00 August 27th, 2019|Categories: Chinese Stocks, IDI, SEC Original|Tags: , , , , , |0 Comments

MOMO [Momo] 6-K: (Original Filing)

[Momo Announces Unaudited Financial Results for the Second Quarter of 2019 BEIJING, CHINA, August 27, 2019 – Momo Inc. (NASDAQ: MOMO) (“Momo” or the “Company”), a leading mobile social networking platform in China, today announced its unaudited financial results for the second quarter of 2019. Second]

By | 2019-08-28T03:49:30+00:00 August 27th, 2019|Categories: Chinese Stocks, MOMO, SEC Original|Tags: , , , , , |0 Comments

UMC [UNITED MICROELECTRONICS] 6-K: (Original Filing)

[www.umc.com Description 99.1 Announcement on 2019/08/09: July Revenue 99.2 Announcement on 2019/08/15: the trading and pledge of UMC common shares by directors, executive officers and 10% shareholders of UMC 1 United Microelectronics Corporation August 9, 2019 This is to report the changes or status]

By | 2019-08-27T12:02:42+00:00 August 27th, 2019|Categories: Chinese Stocks, SEC Original, UMC|Tags: , , , , , |0 Comments

CHL [CHINA MOBILE] 6-K: (Original Filing)

[Number 1.1 , dated August 23, 20 2019 Interim Report • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansion and capital expenditure plans; • the expected impa]

CCM [Concord Medical Services] 6-K: (Original Filing)

[Concord Medical Reports Financial Results for the First Half of 2019 [1] BEIJING, August 23, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagn]

CHL [CHINA MOBILE] 6-K: (Original Filing)

[Number 1.1 , dated August 23, 20 2019 Interim Report • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansion and capital expenditure plans; • the expected impa]

CCM [Concord Medical Services] 6-K: (Original Filing)

[Concord Medical Reports Financial Results for the First Half of 2019 [1] BEIJING, August 23, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagn]

Skip to toolbar